RNA dimerization defect in a Rous sarcoma virus matrix mutant
L J Parent1, T M Cairns, J A Albert
1Department of Medicine, The Pennsylvania State University College of Medicine, M. S. Hershey Medical Center, Hershey, Pennsylvania 17033, USA.
Abstract:
The retrovirus matrix (MA) sequence of the Gag polyprotein has been shown to contain functions required for membrane targeting and binding during particle assembly and budding. Additional functions for MA have been proposed based on the existence of MA mutants in Rous sarcoma virus (RSV), murine leukemia virus, human immunodeficiency virus type 1, and human T-cell leukemia virus type 1 that lack infectivity even though they release particles of normal composition. Here we describe an RSV MA mutant with a surprising and previously unreported phenotype. In the mutant known as Myr1E, the small membrane-binding domain of the Src oncoprotein has been added as an N-terminal extension of Gag. While Myr1E is not infectious, full infectivity can be reestablished by a single amino acid substitution in the Src sequence (G2E), which eliminates the addition of myristic acid and the membrane-binding capacity of this foreign sequence. The presence of myristic acid at the N terminus of the Myr1E Gag protein does not explain its replication defect, because other myristylated derivatives of RSV Gag are fully infectious (e.g., Myr2 [C. R. Erdie and J. W. Wills, J. Virol. 64:5204-5208, 1990]). Biochemical analyses of Myr1E particles reveal that they contain wild-type levels of the Gag cleavage products, Env glycoproteins, and reverse transcriptase activity when measured on an exogenous template. Genomic RNA incorporation appears to be mildly reduced compared to the wild-type level. Unexpectedly, RNA isolated from Myr1E particles is monomeric when analyzed on nondenaturing Northern blots. Importantly, the insertional mutation does not lie within previously identified dimer linkage sites. In spite of the dimerization defect, the genomic RNA from Myr1E particles serves efficiently as a template for reverse transcription as measured by an endogenous reverse transcriptase assay. In marked contrast, after infection of avian cells, the products of reverse transcription are nearly undetectable. These findings might be explained either by the loss of a normal function of MA needed in the formation or stabilization of RNA dimers or by the interference in such events by the mutant MA molecules. It is possible that Myr1E viruses package a single copy of viral RNA.
Insights
A Rous sarcoma virus (RSV) matrix (MA) mutant, Myr1E, shows a replication defect due to impaired genomic RNA dimerization, not myristoylation. Restoring RNA dimerization rescues infectivity, suggesting MA’s role in RNA packaging.
Area of Science:
- Retroviral assembly and replication
- Molecular virology
- Protein-domain interactions
Background:
- The retrovirus matrix (MA) protein is crucial for membrane targeting during virus assembly.
- MA mutants in various retroviruses exhibit defects in infectivity despite normal particle release.
- The function of MA in genomic RNA packaging and dimerization remains incompletely understood.
Purpose of the Study:
- To investigate the function of the Rous sarcoma virus (RSV) MA protein in viral particle assembly and infectivity.
- To characterize a novel RSV MA mutant, Myr1E, with an N-terminal Src oncoprotein domain.
- To determine the role of MA in genomic RNA dimerization and its impact on viral replication.
Main Methods:
- Construction and characterization of the RSV MA mutant Myr1E.
- Biochemical analysis of viral particle composition, including Gag cleavage products, Env glycoproteins, and reverse transcriptase activity.
- Analysis of genomic RNA incorporation, dimerization status, and template activity using Northern blots and reverse transcriptase assays.
- Infectivity assays in avian cells.
Main Results:
- The Myr1E mutant, despite normal particle release and Gag processing, is non-infectious.
- Myristoylation of the N-terminal extension is not the cause of the replication defect.
- Myr1E particles exhibit defective genomic RNA dimerization, with RNA appearing monomeric.
- Genomic RNA from Myr1E particles can serve as a template for reverse transcription in vitro but not in vivo after infection.
Conclusions:
- The replication defect in Myr1E is linked to impaired genomic RNA dimerization, not myristoylation.
- The study suggests a novel role for the MA protein in facilitating or stabilizing genomic RNA dimerization.
- Interference with RNA dimerization by the mutant MA protein may explain the observed block in viral replication.
More Related Videos
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
07:53Visualization and Quantitative Analysis of Genotoxin-Induced PARP1/PARP2 Activation in Cells Using a Fluorescent Fusion Protein-Based Reporter
Published on: April 17, 2026
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
The Ras Gene
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
